Invest in Cancer Innovation
CANCER FUND I
About CANCER FUND I
CANCER FUND is a mission-driven venture capital firm. Our first fund, CANCER FUND I, is an early-stage venture fund supported by a community of physicians, researchers, cancer survivors, patients, and their family friends. We invest in early-stage companies developing and commercializing innovations with the potential to improve outcomes, increase access to care, and reduce the cost of care for patients, survivors, oncologists, health professionals, health systems, and payers that support them.
Investment Details for CANCER FUND I
Increase Survivorship; Reduce Incidence of Mortality; Increase Access to Care; Reduce Cost of Care
Target Number of Companies in Portfolio
Target Number of Investments
30 – 35
Stages of Investment
Pre-Seed; Seed; Seed+; Series A, B, C, and D
Therapies & Management, Diagnostics & Monitoring, Preventions & Enabling Technologies
CANCER FUND I invests in early-stage companies focused on innovation across cancer (pan-cancer) and for specific cancer types including Breast Cancer, Brain Cancer, Lung Cancer, Prostate Cancer, Colon and Rectal Cancer and more.
Bladder Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Glioblastoma, Gynecologic Cancers, Head and Neck Cancers, Hematological Cancers, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Melanoma, Mesothelioma, Myeloma, Ovarian Cancer, Pancreatic Cancer, Pediatric Cancers, Prostate Cancer, Renal Cancer, Skin Cancer, Thyroid Cancer, Uterine Cancer, Vaginal and Vulva Cancers
Target Raise Amount
Price Per Unit
80% of Net Cash Flow distributed to investors with remaining 20% distributed to CANCER FUND I Manager’s affiliate. See Investment Documents in Data Room for details.
2% per annum of the aggregate Capital Contributions to the Manager.